Clinical Trials Logo

Clinical Trial Summary

The high doses of interferon α-2b therapy in patients with melanomas of the skin may induced retinopathy, especially in the patients with hypertension or diabetes, so these patients should be followed up after treatment.


Clinical Trial Description

Patients with melanomas of the skin whose tumors have been resected completely were collected. The detailed ocular examinations including intraocular pressure, slit lamp microscope, indirect ophthalmoscope and color fundus photography were done before the induction therapy, 2 weeks after the induction therapy, after the whole course of induction therapy and each month in the maintenance treatment period. Fundus examinations were carried out by experienced ocular fundus doctors and the retinopathy characteristics were recorded. ;


Study Design

Observational Model: Case-Crossover


Related Conditions & MeSH terms


NCT number NCT02702973
Study type Observational [Patient Registry]
Source First Hospital of Jilin University
Contact Di Wu, doctor
Phone +86-139-4488-8991
Email wudi888991@163.com
Status Recruiting
Phase N/A
Start date December 2015
Completion date October 2017

See also
  Status Clinical Trial Phase
Recruiting NCT02558478 - Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing N/A
Completed NCT01955135 - Anesthesia for Retinopathy of Prematurity Phase 4
Not yet recruiting NCT00331370 - Hypertension Related Damage to the Microcirculation in South Asian: Emergence, Predictive Power and Reversibility N/A
Completed NCT05921981 - Multisensory Stimulation Versus White Noise N/A
Recruiting NCT02466607 - Study of Stimulus Parameters in Flicker Electroretinogram (ERG) N/A
Recruiting NCT01552993 - Registration and Treatment of Pain During Eye Examination of Prematurity N/A
Completed NCT02321904 - Corneal Confocal Microscopy to Detect Diabetic Neuropathy in Children
Completed NCT00259701 - Microvascular Reactivity. N/A
Completed NCT03901898 - Feasibility of an Intervention to Increase Diabetic Retinopathy Screening Attendance N/A
Recruiting NCT06239064 - Early Genetic Identification of Obesity
Recruiting NCT03011541 - Stem Cell Ophthalmology Treatment Study II N/A
Completed NCT01793090 - EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment Phase 2
Withdrawn NCT00618644 - Ranibizumab for Neovascularization in Sickle Cell Retinopathy N/A
Recruiting NCT03542734 - Cognitive Impairment, Retinopathy, and Cerebrovascular Lesions in the Elderly
Active, not recruiting NCT06355219 - Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines
Completed NCT01412905 - Telemedicine Retinal Screening Utilizing a Mobile Medical Unit
Completed NCT00828425 - Management of Diabetes Mellitus Patients With Retinopathy N/A
Not yet recruiting NCT04008121 - Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium Early Phase 1
Terminated NCT00969956 - Time To Complications Occurs in Diabetes
Recruiting NCT04819893 - Study of the Involvement of Fatty Acids in Retinopathy of Prematurity: Relationship Between Retinopathy of Prematurity and the Rate of Expression of Transplacental Fatty Acid Receptors.